clinical trials

News

Immutep mulls filings for LAG-3 drug after new readout

Shares in Immutep have leapt after the biotech reported phase 2b results showing that LAG-3 inhibitor eftilagimod alfa (efti) significantly boosted the efficacy of MSD’s Keytruda in patient

R&D

trend wave with Caroline Redecker and Jason Casarella pictured

Clinical trial trends and the rise of site networks

We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space.

News

uniQure rockets on Huntington’s gene therapy result

Shares in gene therapy developer uniQure have risen more than 75% after the company reported that Huntington’s disease candidate AMT-130 slowed down the progression of the disorder over two

Oncology

Top cancer types, trials, and AI innovations: What HCPs disc...

Kicking off in Chicago on the 31st May, the 2024 American Society of Clinical Oncology’s Annual Meeting - known as ASCO - welcomed more than forty thousand healthcare professionals through

News

Roche’s TIGIT drug linked to worse outcomes in NSCLC trial

Roche’s anti-TIGIT drug tiragolumab has failed a lung cancer study, denting enthusiasm for the programme just as there were signs that it was getting back on track after a series of disappo

News

Advantage J&J in multiple myeloma CAR-T tussle with BMS

Johnson & Johnson and partner Legend Biotech are celebrating a big win in their efforts to expand the use of CAR-T therapy Carvykti for multiple myeloma, after showing a survival benefi

Immutep mulls filings for LAG-3 drug after new readout

Clinical trial trends and the rise of site networks

uniQure rockets on Huntington’s gene therapy result

Top cancer types, trials, and AI innovations: What HCPs disc...

Roche’s TIGIT drug linked to worse outcomes in NSCLC trial

Advantage J&J in multiple myeloma CAR-T tussle with BMS

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

clinical trials

Editor's Picks